Researchers have new hope for HIV vaccine
UC infectious disease expert is featured guest on WVXU
Carl Fichtenbaum, MD, vice chair for clinical research in internal medicine in the University of Cincinnati College of Medicine and renowned HIV expert, recently appeared on WVXU radio's Cincinnati Edition program to talk about the new hope of developing an HIV vaccine.
Though a vaccine is likely still years away, a new injection therapy given several times a year is a game changer, he said.
"HIV should be just a part of the same, general discussions we have about having a healthy lifetime. We don't do that enough. We need to do it more," Fichtenbaum said.
Listen to the full episode online.
Featured image at top of HIV cell: Courtesy of National Institutes of Health
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.